Below are the financial statements of TG Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | — | — | — |
| Product revenue, net | 313.73a | 92.01a | 2.63a |
| License, milestone, royalty and other revenue | 15.28a | 141.66a | 0.15a |
| Total revenue | 329a | 233.66a | 2.79a |
| Costs and expenses | — | — | — |
| Cost of revenue | -38.49a | -14.13a | -0.27a |
| Research and development | — | — | — |
| Noncash compensation | -11.16a | -13.01a | -13.22a |
| Other research and development | -83.13a | -63.18a | -112.13a |
| Total research and development | -94.29a | -76.19a | -125.35a |
| Selling, general and administrative | — | — | — |
| Noncash compensation | -31.38a | -24.92a | -31.44a |
| Other selling, general and administrative | -122.92a | -97.78a | -64.05a |
| Total selling, general and administrative | -154.3a | -122.71a | -95.48a |
| Total costs and expenses | -287.08a | -213.03a | -221.1a |
| Operating income (loss) | 41.93a | 20.63a | -218.32a |
| Other expense (income) | — | — | — |
| Interest expense | -24.03a | -12.62a | -10.19a |
| Other income | -7.69a | -5.04a | -4.7a |
| Total other expense (income), net | 16.34a | 7.57a | 5.5a |
| Net income (loss) before taxes | 25.59a | 13.06a | -223.81a |
| Income taxes | -2.21a | -0.39a | 0a |
| Net income (loss) | 23.38a | 12.67a | -223.81a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore TG Therapeutics’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.